A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation results at three years

Transplantation

Volumn 65, Issue 11, 1998, Pages 1450-1454

  Mathew, Timothy H ^a   Keown, P ^a,b   Hardie, I ^a,c   Isoniemi, H ^a,d   Morris, P ^a,e   Belitsky, P ^a,f   Buchholz, B ^a,g   Walker, R ^a,h   Kirste, G ^a,i   Stiller, C ^a,j   Tiller, D ^a,k   Halloran, P ^a,l   Daloze, P ^a,m   Russel, D ^a,n   Vialtel, P ^a   Binswanger, U ^a,o   Buckels, J A C ^a,p   Touraine, J L ^a,q   Hickey, D ^a,r   Remuzzi, G ^a,s   Lam, F T ^a,t   Navarro, M ^a,u   Ramos, E ^a,u   Rees, M ^a,u   more..

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF HELSINKI   (Finland)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h ROYAL MELBOURNE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

^k ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^l UNIVERSITY OF ALBERTA   (Canada)

^m NOTRE DAME HOSPITAL   (Canada)

ⁿ ST JOSEPH S HOSPITAL   (Canada)

^o Medizinische Klinik Zurich   (Switzerland)

^p QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^q EDOUARD HERRIOT HOSPITAL   (France)

^r BEAUMONT HOSPITAL   (Ireland)

^s MARIO NEGRI INST PHARMACOL RES   (Italy)

^t WALSGRAVE HOSPITAL   (United Kingdom)

^u Roche Global Development   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FUNGEMIA; GASTROINTESTINAL TOXICITY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; VIRUS INFECTION;

CADAVER; DOUBLE-BLIND METHOD; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MYCOPHENOLIC ACID; SURVIVAL ANALYSIS;

EID: 0032526253     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00007     Document Type: Article

References (15)

1. Gulanikar AC, MacDonald AS, Sungertekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
2. Koyama H, Cecka JM. Rejection episodes. Clin Transplant 1992; 6: 391.
3. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307.
4. Almond PS, Matas A, Gillingham KJ, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
5. Tesi RJ, Henry ML, Elkammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 1993; 7: 345.
6. Allison AC, Eugui EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 1993; 14: 353.
7. Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996; 10: 77.
8. Eugui EM, Allison AC. Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 1993; 685: 308.
9. Matthews TR. Discovery and rationale for the development of mycophenolate mofetil. In: Lieberman R, Mukherjee A, eds. Principles of drug development in transplantation and autoimmunity. Austin, TX: R.G. Landes, 1996: 335.
10. Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
11. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 60: 225.
12. Tricontinental Mycophenolate Mofetil Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1929.
13. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C for the International Mycophenolate Mofetil Renal Transplant Study Groups. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39.
14. Naimark DMJ, Cole E. Determinants of long term renal allograft survival. Transplant Rev 1994; 8: 93.
15. Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years: early events affecting transplant success. Transplantation 1992; 53: 59.